RE:ComparisonsDogsbreakfast4U wrote: I have read a few comments mentioning Amazon to illustrate the point that after humble and shaky beginnings it developed into the company we know today and that we should therefore expect the same from WELL. The market however does remember other companies actually involved in the health care sector who were using the roll up strategy that is say Valeant and Concordia HC where things turned out badly for investors. I for one lost a few pennies on Concordia. Is it possible that the market is worried that WELL may turn out to be another roll up failure?
I've always mentioned here that WELL is definitely a "show me" story - they can make all the acquisitions and roll-ups and new releases they want, but investors need to see the financial statements which prove everything out. Q2/Q3 were great. if they can continue their trajectory and get Audited Q4/FYE statements that prove out what they say they're doing, I think that's another catalyst here.
the market is definitely weary of Canadian roll-ups operating in the USA - aka Valeant. CRH Medical's stock was punished and shunned badly because they went on an M&A spree and then their margins took a hit when CMS revised their anesthesia reimbursements (50%+ margins down to 40%+).